Animals
Animals, Newborn
Cell-Derived Microparticles
/ metabolism
Intracellular Fluid
/ drug effects
Lipopolysaccharides
/ toxicity
Male
NF-kappa B
/ metabolism
Phosphorylation
/ drug effects
Sertoli Cells
/ drug effects
Signal Transduction
/ drug effects
Swine
Tumor Necrosis Factor-alpha
/ metabolism
Sertoli cells
lipopolysaccharide
microparticles
nonprofessional tolerogenic
pro-inflammatory pathways
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2020
2020
Historique:
received:
29
09
2020
accepted:
20
11
2020
entrez:
25
1
2021
pubmed:
26
1
2021
medline:
28
5
2021
Statut:
epublish
Résumé
Sertoli cells (SC) are immune privileged cells with the capacity of modulating the immune response by expressing several immune-regulatory factors. SC have the capacity to respond to external stimuli through innate phagocytic and antibacterial activities. This evidence evoked a potential role of SC as drug carriers and therapeutic agents. Such stimuli drive SC towards a still unknown evolution, the clinical relevance of which as yet remains undisclosed. This study sought to investigate the effects of external stimuli in the form of polymeric microparticles (MP) and bacteria derived endotoxins, such as lipopolysaccharides (LPS), in order to identify the pathways potentially involved in cell phenotype modifications. Compared to single stimulation, when combined, MP and LPS provoked a significant increase in the gene expression of IDO, PD-L1, FAS-L, TLR-3, TLR-4, MHC-II, ICAM-1, TFGβ1, BDF123, BDF129, BDF3 and pEP2C. Western Blotting analysis demonstrated up-regulation of the ERK 1-2 and NF-kB p65 phosphorylation ratios. Our study, showing the exponential increase of these mediators upon combined MP and LPS stimulation, suggests a "switch" of SC function from typical cells of the blood-testicular barrier to nonprofessional tolerogenic antigen-presenting cells. Further studies should target the clinical and technological implications of such stimuli-induced SC transformation.
Identifiants
pubmed: 33488524
doi: 10.3389/fendo.2020.611932
pmc: PMC7817811
doi:
Substances chimiques
Lipopolysaccharides
0
NF-kappa B
0
Tumor Necrosis Factor-alpha
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
611932Informations de copyright
Copyright © 2021 Arato, Milardi, Giovagnoli, Grande, Bellucci, Lilli, Bartoli, Corneli, Mazzone, Calvitti, Baroni, Calafiore, Mancuso and Luca.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Toxicol In Vitro. 2018 Apr;48:45-52
pubmed: 29273543
Reproduction. 2010 Mar;139(3):495-504
pubmed: 19995832
Front Endocrinol (Lausanne). 2020 Jun 18;11:401
pubmed: 32625170
Reproduction. 2009 May;137(5):879-88
pubmed: 19225044
Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5808-12
pubmed: 7541137
Biol Reprod. 2011 May;84(5):851-8
pubmed: 21209417
Cell Transplant. 2011;20(5):609-18
pubmed: 21054942
Biomaterials. 2016 Jan;75:313-326
pubmed: 26523508
J Control Release. 2014 Oct 28;192:249-61
pubmed: 25111130
J Infect Dis. 2006 Sep 1;194(5):697-701
pubmed: 16897670
Am J Physiol Regul Integr Comp Physiol. 2005 Jun;288(6):R1744-55
pubmed: 15661966
Mol Membr Biol. 1998 Jul-Sep;15(3):103-21
pubmed: 9859108
Cell Transplant. 2003;12(4):335-49
pubmed: 12911122
Mamm Genome. 2006 Apr;17(4):332-9
pubmed: 16596454
Cell Transplant. 2006;15(1):45-53
pubmed: 16700329
Protein Pept Lett. 2018;25(5):440-445
pubmed: 29651939
CNS Neurosci Ther. 2016 Aug;22(8):686-90
pubmed: 27225886
Biol Reprod. 2008 Feb;78(2):234-42
pubmed: 17989360
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Trends Mol Med. 2009 Apr;15(4):159-68
pubmed: 19303360
Vet Immunol Immunopathol. 2009 May 15;129(1-2):119-25
pubmed: 19131115
Asian J Androl. 2018 Mar-Apr;20(2):160-165
pubmed: 29148520
Dev Biol. 2005 Oct 1;286(1):1-15
pubmed: 16153630
Innate Immun. 2011 Apr;17(2):123-36
pubmed: 20023008
Biomaterials. 2012 Jul;33(21):5333-40
pubmed: 22560198
Hum Reprod. 2006 Nov;21(11):2801-9
pubmed: 16997939
Endocrinology. 2000 Jan;141(1):238-46
pubmed: 10614644
Int J Biochem Cell Biol. 2013 Mar;45(3):621-5
pubmed: 23262290
Annu Rev Biochem. 2002;71:635-700
pubmed: 12045108
J Immunol. 2006 Nov 15;177(10):7122-30
pubmed: 17082629
J Immunol. 2004 Jul 15;173(2):945-54
pubmed: 15240681
Mol Med. 2019 Jun 13;25(1):28
pubmed: 31195953
Xenotransplantation. 2016 Nov;23(6):429-439
pubmed: 27678013
J Exp Med. 2009 Oct 26;206(11):2511-26
pubmed: 19822646
Immunol Today. 1995 Dec;16(12):569-74
pubmed: 8579749
Nat Rev Immunol. 2004 Jul;4(7):499-511
pubmed: 15229469
Nat Rev Immunol. 2004 Oct;4(10):762-74
pubmed: 15459668
Exp Mol Med. 2013 Dec 06;45:e66
pubmed: 24310172
Infect Immun. 2005 May;73(5):2611-20
pubmed: 15845463
Andrology. 2016 Mar;4(2):189-212
pubmed: 26846984
Drug Discov Ther. 2013 Apr;7(2):73-7
pubmed: 23715505
Transplantation. 2010 Dec 27;90(12):1352-7
pubmed: 21197711
Biol Reprod. 2012 Jan 10;86(1):1-14
pubmed: 21900683
Biol Reprod. 1997 Nov;57(5):1115-22
pubmed: 9369178